共 80 条
[1]
Ferlay J(2014)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 E359-E386
[2]
Soerjomataram I(2006)Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11-20
[3]
Dikshit R(2011)Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial J Clin Oncol 29 1715-1721
[4]
Eser S(1996)A comparison of multimodal therapy and surgery for esophageal adenocarcinoma N Engl J Med 335 462-467
[5]
Mathers C(2004)Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma J Clin Oncol 22 2774-2780
[6]
Rebelo M(2005)Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome J Clin Oncol 23 1237-1244
[7]
Parkin DM(2017)Phase II trial of preoperative chemoradiation plus perioperative SOX chemotherapy in patients with locally advanced gastric cancer Journal of Surgical Oncology 117 692-698
[8]
Forman D(2009)Phase III comparing of preoperative chemotherapy with chemoradiotherapy in patients with locally advanced adenocarcinoma of the esophagogastric junction J Clin Oncol 27 851-856
[9]
Bray F(2010)Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study) Ann Oncol 21 1001-1005
[10]
Cunningham D(2012)A phase II study of S-1 and oxaliplatin (SOX) combination chemotherapy as a first-line therapy for patients with advanced gastric cancer Investig New Drugs 30 350-356